Cargando…

Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series

INTRODUCTION: Treatment with various biological agents in disease states such as rheumatoid arthritis has been associated with multiple side effects. Whereas many of these are frequently reported in the literature, hypoglycemia, a possible side effect of tumor necrosis factor-alpha inhibitors, may b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czajkowska, Jadwiga B, Shutty, Brandon, Zito, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266185/ https://www.ncbi.nlm.nih.gov/pubmed/22234148 http://dx.doi.org/10.1186/1752-1947-6-5

Ejemplares similares

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

Human Papillomavirus–Induced Cancer: Late Relapse in a Patient Treated With Tumor Necrosis Factor-Alpha Inhibitor
por: Werberich, Gabriel Madeira, et al.
Publicado: (2016)

The Impacts of a Reading-to-Dog Programme on Attending and Reading of Nine Children with Autism Spectrum Disorders
por: Uccheddu, Stefania, et al.
Publicado: (2019)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
por: Ikediobi, Ogechi, et al.
Publicado: (2015)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus
por: Yen, Chung-Yang, et al.
Publicado: (2022)

Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
por: Hirsch, Julianna, et al.
Publicado: (2016)

Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
por: Reitblat, Tatiana, et al.
Publicado: (2013)

A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy
por: Baird, Timothy, et al.
Publicado: (2016)

Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
por: Masukawa, Ena, et al.
Publicado: (2021)

The Utility of Frequent Laboratory Monitoring for Patients on Tumor Necrosis Factor-Alpha Inhibitors in Dermatology
por: Houpe, Jessica E., et al.
Publicado: (2022)

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series
por: Shabeeb, Nadine, et al.
Publicado: (2021)

The Nine Cancer Frames: A Tool to Facilitate Critical Reading of Cancer-Related Information
por: Murray, Craig, et al.
Publicado: (2021)

Superior Orbital Fissure Syndrome and Ophthalmoplegia Caused by Varicella Zoster Virus with No Skin Eruption in a Patient Treated with Tumor Necrosis Alpha Inhibitor
por: Jensen, Helene, et al.
Publicado: (2015)

110. Improving Pneumococcal Vaccination in Patients Treated with Tumor Necrosis Factor-alpha Inhibitors: A Multidisciplinary Education-Based Quality Improvement Project
por: Curtin, John M, et al.
Publicado: (2022)

The Medical Treatment of Intestinal Obstruction, with a Series of Nine Cases
por: Huntly, William
Publicado: (1893)

Cæsarean Section—With Notes of a Series of Nine Successful Cases
por: Kerr, J. M. Munro
Publicado: (1902)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report
por: Pan, Xiaoli, et al.
Publicado: (2021)

Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
por: Nair, Shaalina, et al.
Publicado: (2022)

Release of tumor necrosis factor-alpha and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin.
por: Beckmann, I, et al.
Publicado: (2001)

Accuracy of blood glucose concentrations determined by four visually read reagent strips
por: MacManus, M P, et al.
Publicado: (1988)

Tumor necrosis factor‐alpha levels in blood cord is directly correlated with the body weight of mothers
por: de Toledo Baldi, E., et al.
Publicado: (2016)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
por: Blow, Tahj, et al.
Publicado: (2021)

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations
por: Accortt, Neil A, et al.
Publicado: (2017)

The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients
por: Yazısız, Veli, et al.
Publicado: (2021)

Simultaneous Improvement of Cutaneous Sarcoidosis and Psoriasis Vulgaris on Administration of a Tumor Necrosis Factor Alpha Inhibitor
por: Kim, Young Shin, et al.
Publicado: (2023)

Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
por: Panse, Ketaki, et al.
Publicado: (2023)

Associations of Tinnitus Incidence with Use of Tumor Necrosis Factor-Alpha Inhibitors among Patients with Autoimmune Conditions
por: Natarajan, Nirvikalpa, et al.
Publicado: (2023)

Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
por: Wood, Patrick R, et al.
Publicado: (2018)

Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease
por: Loganes, Claudia, et al.
Publicado: (2016)

Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia
por: Spaner, David E., et al.
Publicado: (2018)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g5f40p7jth7gdeh218p0brs04p